These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30333168)

  • 1. Human MxB Inhibits the Replication of Hepatitis C Virus.
    Yi DR; An N; Liu ZL; Xu FW; Raniga K; Li QJ; Zhou R; Wang J; Zhang YX; Zhou JM; Zhang LL; An J; Qin CF; Guo F; Li XY; Liang C; Cen S
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30333168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexes.
    Hopkins S; Bobardt M; Chatterji U; Garcia-Rivera JA; Lim P; Gallay PA
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3888-97. PubMed ID: 22585215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A.
    Abe T; Minami N; Bawono RG; Matsui C; Deng L; Fukuhara T; Matsuura Y; Shoji I
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32727878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interferon-inducible MxB protein inhibits HIV-1 infection.
    Liu Z; Pan Q; Ding S; Qian J; Xu F; Zhou J; Cen S; Guo F; Liang C
    Cell Host Microbe; 2013 Oct; 14(4):398-410. PubMed ID: 24055605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MxB Disrupts Hepatitis C Virus NS5A-CypA Complex: Insights From a Combined Theoretical and Experimental Approach.
    Li Q; An N; Yin X; Zhang R; Shao H; Yi D; Cen S
    Front Microbiol; 2022; 13():849084. PubMed ID: 35369502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular Localization of MxB Determines Its Antiviral Potential against Influenza A Virus.
    Steiner F; Pavlovic J
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32907985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach.
    Yang F; Robotham JM; Grise H; Frausto S; Madan V; Zayas M; Bartenschlager R; Robinson M; Greenstein AE; Nag A; Logan TM; Bienkiewicz E; Tang H
    PLoS Pathog; 2010 Sep; 6(9):e1001118. PubMed ID: 20886100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity.
    Nevers Q; Ruiz I; Ahnou N; Donati F; Brillet R; Softic L; Chazal M; Jouvenet N; Fourati S; Baudesson C; Bruscella P; Gelin M; Guichou JF; Pawlotsky JM; Ahmed-Belkacem A
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A.
    Waller H; Chatterji U; Gallay P; Parkinson T; Targett-Adams P
    J Virol Methods; 2010 May; 165(2):202-10. PubMed ID: 20132841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics.
    Kaul A; Stauffer S; Berger C; Pertel T; Schmitt J; Kallis S; Zayas M; Lohmann V; Luban J; Bartenschlager R
    PLoS Pathog; 2009 Aug; 5(8):e1000546. PubMed ID: 19680534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of viral RNA binding and the assembly of infectious hepatitis C virus particles in vitro by cyclophilin inhibitors.
    Nag A; Robotham JM; Tang H
    J Virol; 2012 Dec; 86(23):12616-24. PubMed ID: 22973029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors.
    Chatterji U; Lim P; Bobardt MD; Wieland S; Cordek DG; Vuagniaux G; Chisari F; Cameron CE; Targett-Adams P; Parkinson T; Gallay PA
    J Hepatol; 2010 Jul; 53(1):50-6. PubMed ID: 20451281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexes.
    Chatterji U; Bobardt MD; Lim P; Gallay PA
    J Gen Virol; 2010 May; 91(Pt 5):1189-93. PubMed ID: 20107018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV NS5A and IRF9 compete for CypA binding.
    Bobardt M; Hopkins S; Baugh J; Chatterji U; Hernandez F; Hiscott J; Sluder A; Lin K; Gallay PA
    J Hepatol; 2013 Jan; 58(1):16-23. PubMed ID: 22902549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
    Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
    J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seed sequence-matched controls reveal limitations of small interfering RNA knockdown in functional and structural studies of hepatitis C virus NS5A-MOBKL1B interaction.
    Chung HY; Gu M; Buehler E; MacDonald MR; Rice CM
    J Virol; 2014 Oct; 88(19):11022-33. PubMed ID: 25031347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conserved tandem cyclophilin-binding site in hepatitis C virus nonstructural protein 5A regulates Alisporivir susceptibility.
    Grisé H; Frausto S; Logan T; Tang H
    J Virol; 2012 May; 86(9):4811-22. PubMed ID: 22345441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus NS5B and host cyclophilin A share a common binding site on NS5A.
    Rosnoblet C; Fritzinger B; Legrand D; Launay H; Wieruszeski JM; Lippens G; Hanoulle X
    J Biol Chem; 2012 Dec; 287(53):44249-60. PubMed ID: 23152499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.
    Wang Y; Li J; Wang X; Ye L; Zhou Y; Thomas RM; Ho W
    Innate Immun; 2014 Jan; 20(1):3-11. PubMed ID: 23529855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication.
    Polyak SJ; Paschal DM; McArdle S; Gale MJ; Moradpour D; Gretch DR
    Hepatology; 1999 Apr; 29(4):1262-71. PubMed ID: 10094974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.